Large deletions induced by Cas9 cleavage
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Adikusama et al. detected large deletions between 100bp and 2.3kb in 45% of 127 early mouse embryos using long-range PCR.
“Adikusama et al. targeted six genes in a total of 127 early mouse embryos and detected large deletions (between 100bp and 2.3kb) in 45% of their samples using long-range PCR (10).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [10]
The 'Large deletions induced by Cas9 cleavage' section reports deletions over 100 bp in 57 of 127 samples (45%) using larger PCR products, with a maximum deletion of 2.3 kb. The 'Sample size' section identifies six targeted loci but calls the 127 subjects 'founder embryos/mice,' not exclusively early mouse embryos. (LLM, conf=0.88)
Experimental — accuracy not yet measuredCRISPR-Cas9-induced deletions larger than the PCR fragment can eliminate one or both primer annealing sites, leading to amplification of only one allele and a false impression of unsuccessful targeting or a single homozygous event.
“CRISPR-Cas9-induced deletions larger than these fragments in either direction would eliminate one or both PCR primer annealing sites.This in turn can lead to amplification of only one allele, giving the false impression that targeting was unsuccessful or that there is a single homozygous event at the on-target site (9,10,15).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [10]
Large deletions were generally more prevalent when targeting intronic regions (>70%) than exons (20%).
“Of note, large deletions were generally more prevalent when they targeted intronic regions (>70%) than when they targeted exons (20%).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [10]
The “Large deletions induced by Cas9 cleavage” section reports large-deletion frequencies, but does not compare intronic and exonic targets. Searches for intronic and exonic targeting and the stated percentages found no passage supporting the >70% versus 20% comparison; the copy’s mention of approximately 20% concerns edited mouse embryonic stem cells, not exons. (LLM, conf=0.72)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339 · see citing works
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133 · see citing works
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495 · see citing works
Kosicki, M., Tomberg, K., & Bradley, A. (2018) · Nature Biotechnology · doi:10.1038/nbt.4192 · Cited by 1,883 · see citing works
Correction of a pathogenic gene mutation in human embryos
Ma, H., Marti-Gutierrez, N., Park, S.-W., Wu, J., Lee, Y., Suzuki, K., Koski, A., Ji, D., Hayama, T., Ahmed, R., et al. (2017) · Nature · doi:10.1038/nature23305 · Cited by 969 · see citing works
CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome
Shin, H. Y., Wang, C., Lee, H., Yoo, K. H., Zeng, X., Kuhns, T. M., Yang, C. M., Mohr, T., Liu, C., & Hennighausen, L. G. (2017) · Nature Communications · doi:10.1038/ncomms15464 · Cited by 303 · see citing works
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
Zuckermann, M., Hovestadt, V., Knobbe-Thomsen, C. B., Zapatka, M., Northcott, P. A., Schramm, K., Belic, J., Jones, D., Tschida, B. R., Moriarity, B. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8391 · Cited by 294 · see citing works
Inter-homologue repair in fertilized human eggs?
Egli, D., Zuccaro, M. V., Kosicki, M., Church, G. M., Bradley, A., & Jasin, M. (2018) · Nature · doi:10.1038/s41586-018-0379-5 · Cited by 111 · see citing works
Parikh, B. A., Beckman, D. L., Patel, S. J., White, J. M., & Yokoyama, W. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116484 · Cited by 55 · see citing works
Efficient Detection, Quantification and Enrichment of Subtle Allelic Alterations
Chen, J., Zhang, X., Wang, T., Li, Z., Guan, G., & Hong, Y. (2012) · DNA Research · doi:10.1093/dnares/dss023 · Cited by 55 · see citing works
Efficient Zygotic Genome Editing via RAD51-Enhanced Interhomolog RepairPreprint
Wilde, J. J., Aida, T., Wienisch, M., Zhang, Q., Qi, P., & Feng, G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/263699 · Cited by 17 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Whitworth, K. M. et al. Use of the CRISPR/Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos. Biol. Reprod. 91, 78 (2014).
- Baker, T. G. A quantitative and cytological study of germ cells in human ovaries. Proc. R. Soc. Lond. B 158, 417-433 (1963).
- Egli, D. et al. Reprogramming within hours following nuclear transfer into mouse but not human zygotes. Nature Commun. 2, 488 (2011).
- Suzuki, T., Asami, M. & Perry, A. C. Asymmetric parental genome engineering by Cas9 during mouse meiotic exit. Sci. Rep. 4, 7621 (2014). Received: 29 August 2017; Accepted: 5 April 2018.
- Shin, H. Y. et al. CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 8, 15464 (2017).
- Parikh, B. A., Beckman, D. L., Patel, S. J., White, J. M. & Yokoyama, W. M. Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing. PLoS One 10, e0116484 (2015).
- Shin, H. Y. et al. CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 8, 15464 (2017).
- Filler Hayut, S., Melamed Bessudo, C. & Levy, A. A. Targeted recombination between homologous chromosomes for precise breeding in tomato. Nat. Commun. 8, 15605 (2017).
Cited by
Sorted by citations
CRISPR/Cas9 therapeutics: progress and prospects
Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., He, X., Liu, M., Li, P., & Yu, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01309-7 · Cited by 770 · see citing works
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
Leibowitz, M. L., Papathanasiou, S., Doerfler, P. A., Blaine, L. J., Sun, L., Yao, Y., Zhang, C.-Z., Weiss, M. J., & Pellman, D. (2021) · Nature Genetics · doi:10.1038/s41588-021-00838-7 · Cited by 583 · see citing works
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Wang, D., Zhang, F., & Gao, G. (2020) · Cell · doi:10.1016/j.cell.2020.03.023 · Cited by 526 · see citing works
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
Cullot, G., Boutin, J., Toutain, J., Prat, F., Pennamen, P., Rooryck, C., Teichmann, M., Rousseau, E., Lamrissi-Garcia, I., Guyonnet-Duperat, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09006-2 · Cited by 474 · see citing works
DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Xue, C., & Greene, E. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.02.008 · Cited by 431 · see citing works
Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos
Zuccaro, M. V., Xu, J., Mitchell, C., Marin, D., Zimmerman, R., Rana, B., Weinstein, E., King, R. T., Palmerola, K. L., Smith, M. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.025 · Cited by 303 · see citing works
CRISPR technologies for genome, epigenome and transcriptome editing
Villiger, L., Joung, J., Koblan, L. W., Weissman, J. S., Abudayyeh, O. O., & Gootenberg, J. S. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00697-6 · Cited by 264 · see citing works
Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos
Alanis-Lobato, G., Zohren, J., McCarthy, A., Fogarty, N. M. E., Kubikova, N., Hardman, E., Greco, M., Wells, D., Turner, J. M. A., & Niakan, K. K. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004832117 · Cited by 234 · see citing works
Genotoxic effects of base and prime editing in human hematopoietic stem cells
Fiumara, M., Ferrari, S., Omer-Javed, A., Beretta, S., Albano, L., Canarutto, D., Varesi, A., Gaddoni, C., Brombin, C., Cugnata, F., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01915-4 · Cited by 220 · see citing works
CRISPR-based genome editing through the lens of DNA repair
Nambiar, T. S., Baudrier, L., Billon, P., & Ciccia, A. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.026 · Cited by 224 · see citing works
Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
Nahmad, A. D., Reuveni, E., Goldschmidt, E., Tenne, T., Liberman, M., Horovitz‐Fried, M., Khosravi, R., Kobo, H., Reinstein, E., Madi, A., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01377-0 · Cited by 235 · see citing works
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
Tsuchida, C. A., Brandes, N., Bueno, R., Trinidad, M. I., Mazumder, T., Yu, B., Hwang, B., Chang, C. R., Liu, J., Sun, Y., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.041 · Cited by 210 · see citing works
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
Tao, J., Bauer, D. E., & Chiarle, R. (2023) · Nature Communications · doi:10.1038/s41467-023-35886-6 · Cited by 216 · see citing works
In vivo prime editing of a metabolic liver disease in mice
Böck, D., Rothgangl, T., Villiger, L., Schmidheini, L., Matsushita, M., Mathis, N., Ioannidi, E. I., Rimann, N., Grisch‐Chan, H. M., Kreutzer, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl9238 · Cited by 199 · see citing works
Höijer, I., Emmanouilidou, A., Östlund, R., van Schendel, R., Bozorgpana, S., Tijsterman, M., Feuk, L., Gyllensten, U. B., den Hoed, M., & Ameur, A. (2022) · Nature Communications · doi:10.1038/s41467-022-28244-5 · Cited by 189 · see citing works
Development of CRISPR-Cas systems for genome editing and beyond
Zhang, F. (2019) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583519000052 · Cited by 185 · see citing works
Zhang, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30064 · Cited by 182 · see citing works
Precision genome editing using cytosine and adenine base editors in mammalian cells
Huang, T. P., Newby, G. A., & Liu, D. R. (2021) · Nature Protocols · doi:10.1038/s41596-020-00450-9 · Cited by 175 · see citing works
Assessment of Cas12a‐mediated gene editing efficiency in plants
Bernabé‐Orts, J. M., Casas‐Rodrigo, I., Minguet, E. G., Landolfi, V., García‐Carpintero, V., Gianoglio, S., Vázquez‐Vilar, M., Granell, A., & Orzáez, D. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13113 · Cited by 148 · see citing works
Lampe, G. D., King, R. T., Halpin-Healy, T. S., Klompe, S. E., Hogan, M. I., Vo, P. L. H., Tang, S., Chavez, A., & Sternberg, S. H. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01748-1 · Cited by 143 · see citing works
Huang, T., & Puchta, H. (2019) · Plant Cell Reports · doi:10.1007/s00299-019-02379-0 · Cited by 144 · see citing works
Microhomologies are prevalent at Cas9-induced larger deletions
Owens, D. D. G., Caulder, A., Frontera, V., Harman, J. R., Allan, A. J., Bucakci, A., Greder, L., Codner, G. F., Hublitz, P., McHugh, P. J., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz459 · Cited by 136 · see citing works
Ferrari, S., Jacob, A., Cesana, D., Laugel, M., Beretta, S., Varesi, A., Unali, G., Conti, A., Canarutto, D., Albano, L., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.09.001 · Cited by 133 · see citing works
Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing
Papathanasiou, S., Markoulaki, S., Blaine, L. J., Leibowitz, M. L., Zhang, C., Jaenisch, R., & Pellman, D. S. (2021) · Nature Communications · doi:10.1038/s41467-021-26097-y · Cited by 129 · see citing works
Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL
Diorio, C. J., Murray, R. C., Naniong, M., Barrera, L. A., Camblin, A. J., Chukinas, J. A., Coholan, L. J., Edwards, A., Fuller, T. J., Gonzales, C., et al. (2022) · Blood · doi:10.1182/blood.2022015825 · Cited by 133 · see citing works
Detection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing
Weisheit, I., Kroeger, J. A., Malik, R., Klimmt, J., Crusius, D., Dannert, A., Dichgans, M., & Paquet, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107689 · Cited by 125 · see citing works
Expanding the CRISPR Toolbox in Zebrafish for Studying Development and Disease
Liu, K., Petree, C., Requena, T., Varshney, P., & Varshney, G. K. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00013 · Cited by 138 · see citing works
Hunt, J., Samson, C., du Rand, A., & Sheppard, H. M. (2023) · Human Genetics · doi:10.1007/s00439-023-02561-1 · Cited by 125 · see citing works
Simultaneous precise editing of multiple genes in human cells
Riesenberg, S., Chintalapati, M., Macak, D., Kanis, P., Maričić, T., & Pääbo, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz669 · Cited by 122 · see citing works
Cas9-induced large deletions and small indels are controlled in a convergent fashion
Kosicki, M., Allen, F., Steward, F., Tomberg, K., Pan, Y., & Bradley, A. (2022) · Nature Communications · doi:10.1038/s41467-022-30480-8 · Cited by 115 · see citing works
Efficient precise in vivo base editing in adult dystrophic mice
Xu, L. M., Zhang, C., Bailin, P. L., Wang, P., Gao, Y., Mohler, P. J., Mokadam, N. A., Ma, J., Arnold, W. D., & Han, R. (2021) · Nature Communications · doi:10.1038/s41467-021-23996-y · Cited by 109 · see citing works
Inter-homologue repair in fertilized human eggs?
Egli, D., Zuccaro, M. V., Kosicki, M., Church, G. M., Bradley, A., & Jasin, M. (2018) · Nature · doi:10.1038/s41586-018-0379-5 · Cited by 111 · see citing works
Global detection of DNA repair outcomes induced by CRISPR–Cas9
Liu, M., Zhang, W., Xin, C., Yin, J., Shang, Y., Chen, A., Li, J., Meng, F., & Hu, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab686 · Cited by 109 · see citing works
Bennett, E., Petersen, B. L., Johansen, I. E., Niu, Y., Yang, Z., Chamberlain, C. A., Met, Ö., Wandall, H. H., & Frödin, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa975 · Cited by 103 · see citing works
Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing
Yin, J., Lu, R., Xin, C., Wang, Y., Ling, X., Li, D., Zhang, W., Liu, M., Xie, W., Kong, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28900-w · Cited by 96 · see citing works
Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases
Lim, K., Cho, S.-I., & Kim, J. (2022) · Nature Communications · doi:10.1038/s41467-022-27962-0 · Cited by 100 · see citing works
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges
Kalter, N., Fuster‐García, C., Silva, A., Ronco-Díaz, V., Roncelli, S., Turchiano, G., Gorodkin, J., Cathomen, T., Benabdellah, K., Lee, C. M., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102636 · Cited by 107 · see citing works
Park, S. H., Cao, M., Pan, Y., Davis, T., Saxena, L., Deshmukh, H., Fu, Y., Treangen, T. J., Sheehan, V., & Bao, G. (2022) · Science Advances · doi:10.1126/sciadv.abo7676 · Cited by 92 · see citing works
Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9
Stephens, C. J., Lauron, E. J., Kashentseva, E. A., Lu, Z. H., Yokoyama, W. M., & Curiel, D. T. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.009 · Cited by 89 · see citing works
Yu, M., Hu, S., Tang, B., Yang, H., & Sun, D. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108202 · Cited by 92 · see citing works
Efficient high-precision homology-directed repair-dependent genome editing by HDRobust
Riesenberg, S., Kanis, P., Macak, D., Wollny, D., Düsterhöft, D., Kowalewski, J., Helmbrecht, N., Maričić, T., & Pääbo, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01949-1 · Cited by 87 · see citing works
Optimized nickase- and nuclease-based prime editing in human and mouse cells
Adikusuma, F., Lushington, C., Arudkumar, J., Godahewa, G. I., Chey, Y. C. J., Gierus, L., Piltz, S., Geiger, A., Jain, Y., Reti, D., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab792 · Cited by 87 · see citing works
Self-citationFrequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
Tao, J., Wang, Q., Mendez‐Dorantes, C., Burns, K. H., & Chiarle, R. (2022) · Nature Communications · doi:10.1038/s41467-022-31322-3 · Cited by 88 · see citing works
Pavani, G., Fabiano, A., Laurent, M., Amor, F., Cantelli, E., Chalumeau, A., Maule, G., Tachtsidi, A., Concordet, J., Cereseto, A., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020001996 · Cited by 86 · see citing works
Efficient embryonic homozygous gene conversion via RAD51-enhanced interhomolog repair
Wilde, J. J., Aida, T., del Rosario, R. C. H., Kaiser, T., Qi, P., Wienisch, M., Zhang, Q., Colvin, S. M., & Feng, G. (2021) · Cell · doi:10.1016/j.cell.2021.04.035 · Cited by 93 · see citing works
Genome editing methods in animal models
Lee, H., Yoon, D. E., & Kim, K. (2020) · Animal Cells and Systems · doi:10.1080/19768354.2020.1726462 · Cited by 81 · see citing works
Sanjurjo-Soriano, C., Erkilic, N., Baux, D., Mamaeva, D. V., Hamel, C., Meunier, I., Roux, A., & Kalatzis, V. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.016 · Cited by 77 · see citing works
Boutin, J., Rosier, J., Cappellen, D., Prat, F., Toutain, J., Pennamen, P., Bouron, J., Rooryck, C., Merlio, J., Lamrissi‐Garcia, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25190-6 · Cited by 78 · see citing works
Large-Fragment Deletions Induced by Cas9 Cleavage while Not in the BEs System
Song, Y., Liu, Z., Zhang, Y., Chen, M., Sui, T., Lai, L., & Li, Z. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.06.019 · Cited by 72 · see citing works
Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa
Meng, D., Ragi, S. D., & Tsang, S. H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.08.012 · Cited by 72 · see citing works
Schimmel, J., Muñoz-Subirana, N., Kool, H., van Schendel, R., van der Vlies, S., Kamp, J. A., de Vrij, F. M. S., Kushner, S. A., Smith, G. C. M., Boulton, S. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112019 · Cited by 71 · see citing works
Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
Azeez, S. S., Hamad, R. S., Hamad, B., Shekha, M. S., & Bergsten, P. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1509924 · Cited by 84 · see citing works
Principles of and strategies for germline gene therapy
Wolf, D. P., Mitalipov, P. A., & Mitalipov, S. M. (2019) · Nature Medicine · doi:10.1038/s41591-019-0473-8 · Cited by 73 · see citing works
Wen, W., Quan, Z.-J., Li, S.-A., Yang, Z.-X., Fu, Y.-W., Zhang, F., Li, G., Zhao, M., Yin, M., Xu, J., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02462-4 · Cited by 73 · see citing works
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
Ferrari, S., Valeri, E., Conti, A., Scala, S., Aprile, A., Micco, R. D., Kajaste‐Rudnitski, A., Montini, E., Ferrari, G., Aiuti, A., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.04.014 · Cited by 71 · see citing works
van de Kooij, B., Kruswick, A., van Attikum, H., & Yaffe, M. B. (2022) · Nature Communications · doi:10.1038/s41467-022-32743-w · Cited by 69 · see citing works
Gene editing and its applications in biomedicine
Li, G., Li, X., Zhuang, S., Wang, L., Zhu, Y., Chen, Y., Sun, W. C., Wu, Z., Zhou, Z. L., Chen, J., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2057-0 · Cited by 65 · see citing works
Simkin, D., Papakis, V., Bustos, B. I., Ambrosi, C. M., Ryan, S. J., Baru, V., Williams, L. A., Dempsey, G. T., McManus, O. B., Landers, J. E., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.008 · Cited by 66 · see citing works
Hwang, G., Lee, S., Oh, M., Kim, S., Habib, O., Jang, H., Kim, H. S., Kim, Y., Kim, C. H., Kim, S., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01277-5 · Cited by 72 · see citing works
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Demirci, S., Leonard, A. K., Haro‐Mora, J. J., Uchida, N., & Tisdale, J. F. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_331 · Cited by 67 · see citing works
In-depth assessment of the PAM compatibility and editing activities of Cas9 variants
Zhang, W., Yin, J., Zhangding, Z., Xin, C., Liu, M., Wang, Y., Chen, A., & Hu, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab507 · Cited by 63 · see citing works
CRISPR gene editing in human embryos wreaks chromosomal mayhem
Ledford, H. K. (2020) · Nature · doi:10.1038/d41586-020-01906-4 · Cited by 64 · see citing works
Marchetti, F., Cardoso, R., Chen, C. L., Douglas, G. R., Elloway, J. M., Escobar, P. A., Harper, T. A., Heflich, R. H., Kidd, D., Lynch, A. M., et al. (2023) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2023.108466 · Cited by 65 · see citing works
Lea, R. A., & Niakan, K. K. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0424-0 · Cited by 62 · see citing works
ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
Boutin, J., Cappellen, D., Rosier, J., Amintas, S., Dabernat, S., Bedel, A., & Moreau‐Gaudry, F. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0120 · Cited by 57 · see citing works
Bayraktar, E. C., La, K., Karpman, K., Ünlü, G., Özerdem, C., Ritter, D., Alwaseem, H., Molina, H., Hoffmann, H.-H., Millner, A., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0206-9 · Cited by 61 · see citing works
Jo, D. H., Jang, H., Cho, C. S., Han, J. H., Ryu, G., Jung, Y., Bae, S., & Kim, J. H. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.11.021 · Cited by 61 · see citing works
Engineering strategies to safely drive CAR T-cells into the future
Rossi, M., & Breman, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1411393 · Cited by 64 · see citing works
Recent advances in therapeutic gene-editing technologies
Liu, D., Cao, D., & Han, R. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.026 · Cited by 62 · see citing works
Harnessing DSB repair to promote efficient homology-dependent and -independent prime editing
Peterka, M., Akrap, N., Li, S., Wimberger, S., Hsieh, P.-P., Degtev, D., Bestas, B., Barr, J., van de Plassche, S., Mendoza-García, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28771-1 · Cited by 56 · see citing works
CRISPR technology: The engine that drives cancer therapy
Zhang, M., Eshraghian, E. A., Jammal, O. A., Zhang, Z.-B., & Zhu, X. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111007 · Cited by 54 · see citing works
Turocy, J. M., Adashi, E. Y., & Egli, D. M. (2021) · Cell · doi:10.1016/j.cell.2021.02.036 · Cited by 53 · see citing works
The contribution of DNA repair pathways to genome editing and evolution in filamentous pathogens
Huang, J. T., & Cook, D. E. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac035 · Cited by 52 · see citing works
Lazar, N. H., Çelik, S., Chen, L., Fay, M. M., Irish, J. C., Jensen, J., Tillinghast, C. A., Urbanik, J., Bone, W. P., Roberts, G. H. L., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01758-y · Cited by 51 · see citing works
Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins
Xu, D. Z., Besselink, S., Ramadoss, G. N., Dierks, P. H., Lubin, J. P., Pattali, R. K., Brim, J. I., Christenson, A. E., Colias, P. J., Ornelas, I. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63167-x · Cited by 53 · see citing works
Recent advances in functional genomics for parasitic nematodes of mammals
Castelletto, M. L., Gang, S. S., & Hallem, E. A. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.206482 · Cited by 52 · see citing works
Gelinsky, E., & Hilbeck, A. (2018) · Environmental Sciences Europe · doi:10.1186/s12302-018-0182-9 · Cited by 51 · see citing works
Xu, L. M., Lau, Y. S., Gao, Y., Bailin, P. L., & Han, R. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.001 · Cited by 50 · see citing works
CRISPR–Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics
Zhu, G., Zhou, X., Wen, M., Qiao, J., Guo, L., & Yao, Y. (2024) · BioDesign Research · doi:10.34133/bdr.0041 · Cited by 53 · see citing works
Causal machine learning for single-cell genomics
Tejada-Lapuerta, A., Bertin, P., Bauer, S., Aliee, H., Bengio, Y., & Theis, F. J. (2025) · Nature Genetics · doi:10.1038/s41588-025-02124-2 · Cited by 47 · see citing works
Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing
Zhang, X., Li, T., Ou, J., Huang, J., & Liang, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00838-7 · Cited by 47 · see citing works
The design and engineering of synthetic genomes
James, J. S., Dai, J., Chew, W. L., & Cai, Y. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00786-y · Cited by 48 · see citing works
Ma, H., Martí‐Gutiérrez, N., Park, S.-W., Wu, J., Hayama, T., Darby, H., Dyken, C. V., Li, Y., Koski, A., Liang, D., et al. (2018) · Nature · doi:10.1038/s41586-018-0381-y · Cited by 45 · see citing works
Liu, S.-C., Feng, Y.-L., Sun, X., Chen, R.-D., Liu, Q., Xiao, J., Zhang, J., Huang, Z., Xiang, J.-F., Chen, G., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02736-5 · Cited by 42 · see citing works
State-of-the-Art 2019 on Gene Therapy for Phenylketonuria
Grisch‐Chan, H. M., Schwank, G., Harding, C. O., & Thöny, B. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.111 · Cited by 43 · see citing works
Huang, J. T., Rowe, D., Subedi, P., Zhang, W., Suelter, T., Valent, B. S., & Cook, D. E. (2022) · Nature Communications · doi:10.1038/s41467-022-34736-1 · Cited by 41 · see citing works
CRISPR-based strategies for targeted transgene knock-in and gene correction
Lau, C., Tin, C., & Suh, Y. (2020) · Faculty Reviews · doi:10.12703/r/9-20 · Cited by 41 · see citing works
Alariqi, M., Ramadan, M., Yu, L., Hui, F., Hussain, A., Zhou, X., Yu, Y., Zhang, X., & Jin, S. (2025) · Advanced Science · doi:10.1002/advs.202416331 · Cited by 42 · see citing works
A CRISPR endonuclease gene drive reveals distinct mechanisms of inheritance bias
Verkuijl, S. A. N., González, E., Li, M., Ang, J. X. D., Kandul, N. P., Anderson, M. A. E., Akbari, O. S., Bonsall, M. B., & Alphey, L. (2022) · Nature Communications · doi:10.1038/s41467-022-34739-y · Cited by 40 · see citing works
Factors affecting the cleavage efficiency of the CRISPR-Cas9 system
Jung, W. J., Park, S.-J., Cha, S., & Kim, K. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2322054 · Cited by 39 · see citing works
Epigenetic Regulation of Aging and its Rejuvenation
An, Y., Wang, Q., Gao, K., Zhang, C., Ouyang, Y., Li, R., Zhou, M., Wu, T., Zhou, L., Xie, Z., et al. (2025) · MedComm · doi:10.1002/mco2.70369 · Cited by 44 · see citing works
Long-read individual-molecule sequencing reveals CRISPR-induced genetic heterogeneity in human ESCs
Bi, C., Wang, L., Yuan, B., Zhou, X., Pang, Y., Li, Y., Wang, S., Gao, X., Huang, Y., & Li, M. (2020) · Genome biology · doi:10.1186/s13059-020-02143-8 · Cited by 38 · see citing works
The Challenges in Developing Efficient and Robust Synthetic Homing Endonuclease Gene Drives
Verkuijl, S. A. N., Ang, J. X. D., Alphey, L., Bonsall, M. B., & Anderson, M. A. E. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.856981 · Cited by 36 · see citing works
CRISPR–Cas9 gene editing induced complex on-target outcomes in human cells
Wen, W., & Zhang, X. (2022) · Experimental Hematology · doi:10.1016/j.exphem.2022.03.002 · Cited by 38 · see citing works
Li, J., Shen, Z., Liu, Y., Yan, Z., Liu, Y., Lin, X., Tang, J., Lv, R., Geng, G., Xiong, Z., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.015 · Cited by 39 · see citing works
Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9
Cullot, G., Boutin, J., Fayet, S., Prat, F., Rosier, J., Cappellen, D., Lamrissi‐Garcia, I., Pennamen, P., Bouron, J., Amintas, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39632-w · Cited by 38 · see citing works
Collateral damage and CRISPR genome editing
Thomas, M., Burgio, G., Adams, D. J., & Iyer, V. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1007994 · Cited by 38 · see citing works
Efficient base editing by RNA-guided cytidine base editors (CBEs) in pigs
Yuan, H., Yu, T., Wang, L., Yang, L., Zhang, Y., Liu, H., Li, M., Tang, X., Liu, Z., Li, Z., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03205-2 · Cited by 38 · see citing works
Targeted Gene Delivery: Where to Land
Pavani, G., & Amendola, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.609650 · Cited by 40 · see citing works
Simple and reliable detection of CRISPR-induced on-target effects by qgPCR and SNP genotyping
Weisheit, I., Kroeger, J. A., Malik, R., Wefers, B., Lichtner, P., Wurst, W., Dichgans, M., & Paquet, D. (2021) · Nature Protocols · doi:10.1038/s41596-020-00481-2 · Cited by 33 · see citing works
- Authors
- Adikusuma, F., Piltz, S., Corbett, M. A., Turvey, M., McColl, S. R., Helbig, K. J., Beard, M. R., Hughes, J., Pomerantz, R. T., & Thomas, P. Q.
- Affiliations
- Diponegoro University (ID)
- South Australian Health and Medical Research Institute (AU)
- The University of Adelaide (AU)
- Singapore-MIT Alliance for Research and Technology (SG)
- La Trobe University (AU)
- Temple University (US)
- Corresponding author
- Thomas, Paul Q.
- ORCID
- Venue
- Nature
- Published
- 2018-08
- Volume
- 560
- Issue
- 7717
- Pages
- E8-E9
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2885661865
- Cited by
- 371
- References
- 8
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 63 · 2023: 60 · 2022: 69 · 2021: 44 · 2020: 41 · 2019: 26 · 2018: 10
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Oregon Health and Science University
- Leona M. and Harry B. Helmsley Charitable Trust
- South Australian Health and Medical Research Institute
- Temple University
- Consorzio Interuniversitario Biotecnologie
- Moxie Foundation
- La Trobe University
- University of Adelaide
- Government of Jiangxi Province
- Universitas Diponegoro
- Institute for Basic Science (IBSR021-D1, R021-D1)
- Directorate for Biological Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- CRISPR/Cas9 genome editing, MYBPC3 mutation, large deletions, DNA double-strand break repair, mouse embryo model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
